Browse by Title

Type here to filter the list

T
Ten-year trajectories of multimorbidity and impact on polypharmacy in older people

Marc Simard (he/him/his) – Laval University ### 1062929###Presenting Author###PhD Candidate, Biostatistician###Laval University###
Presenting Author: Marc Simard (he/him/his) – Laval University
### he/him/his @@@ Elham Rahme, PhD – Institut de recherche du centre universitaire de santé McGill, Montréal, QC, Canada ### 1358488###Co-Author###Associate Professor###Institut de recherche du centre universitaire de santé McGill, Montréal, QC, Canada###
Co-Author: Elham Rahme, PhD – Institut de recherche du centre universitaire de santé McGill, Montréal, QC, Canada
### @@@ Marjolaine Dubé – Institut national de santé publique du Québec, Québec, QC, Canada ### 1658987###Co-Author######Institut national de santé publique du Québec, Québec, QC, Canada###
Co-Author: Marjolaine Dubé – Institut national de santé publique du Québec, Québec, QC, Canada
### @@@ Véronique Boiteau – Institut national de santé publique du Québec, Québec, QC, Canada ### 1658988###Co-Author###Conseillère scientifique###Institut national de santé publique du Québec, Québec, QC, Canada###
Co-Author: Véronique Boiteau – Institut national de santé publique du Québec, Québec, QC, Canada
### @@@ Denis Talbot, PhD (he/him/his) – Universite Laval ### 1360377###Co-Author###Professor###Universite Laval###
Co-Author: Denis Talbot, PhD (he/him/his) – Universite Laval
### he/him/his @@@ Caroline Sirois – Université Laval, faculté de pharmacie ### 1656008###Co-Author###Professor-researcher###Université Laval, faculté de pharmacie###
Co-Author: Caroline Sirois – Université Laval, faculté de pharmacie
###
The "Sea" of Cancer

Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration ### 1358504###Co-Moderator###Associate Director of Pharmacoepidemiology###Oncology Center of Excellence, US Food and Drug Administration###
Co-Moderator: Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration
### @@@ Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc. ### 1991390###Co-Moderator###Executive Director, Head of Epidemiology and Risk Management Operation###BeiGene USA, Inc.###
Co-Moderator: Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc.
### he/him/his
The Association Between Pre-Existing Type 2 Diabetes on Breast Cancer-Related and Overall Mortality Among Women with Breast Cancer

Kristina Parsons, RD – McGill University ### 1991163###Presenting Author###Master's Student###McGill University###
Presenting Author: Kristina Parsons, RD – McGill University
### @@@ Hui Yin, MSc – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada ### 1397870###Co-Author######The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada###
Co-Author: Hui Yin, MSc – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada
### @@@ Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada ### 1358432###Co-Author###Assistant Professor###Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada###
Co-Author: Oriana HY Yu, MD MSc – Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada
### @@@ Farzin Khosrow-Khavar, PhD – Rutgers University ### 1658459###Co-Author###Instructor###Rutgers University###
Co-Author: Farzin Khosrow-Khavar, PhD – Rutgers University
### @@@ Laurent Azoulay, PhD – McGill University ### 1302855###Co-Author###Associate Professor###McGill University###
Co-Author: Laurent Azoulay, PhD – McGill University
###
The Augmentation Therapy and Suicide Risk in Patients with Treatment-Resistant Depression Using Target Trial Emulation Framework

Daniel Hsiang-Te Tsai, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1658474###Presenting Author###PhD student###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Presenting Author: Daniel Hsiang-Te Tsai, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Avery Shuei He Yang – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1658473###Co-Author###Research Associate###School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Avery Shuei He Yang – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Zi Xuan Wong – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358891###Co-Author######School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Zi Xuan Wong – School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1358157###Co-Author###Associate Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/his
The Comparative Effectiveness and Safety of Amoxicillin Alone versus Amoxicillin/Clavulanate for the Outpatient Treatment of Acute Sinusitis in Children

Timothy J. Savage, MD, MPH, MSc (he/him/his) – Brigham and Women's Hospital / Harvard Medical School ### 1991201###Presenting Author###Associate Epidemiologist / Instructor in Medicine###Brigham and Women's Hospital / Harvard Medical School###
Presenting Author: Timothy J. Savage, MD, MPH, MSc (he/him/his) – Brigham and Women's Hospital / Harvard Medical School
### he/him/his @@@ Matthew P. Kronman, MD, MSCE – Seattle Children's Hospital / University of Washington ### 1991389###Co-Author###Professor, Pediatric Infectious Diseases###Seattle Children's Hospital / University of Washington###
Co-Author: Matthew P. Kronman, MD, MSCE – Seattle Children's Hospital / University of Washington
### @@@ Sushama Kattinakere Sreedhara, MBBS, MSPH – Brigham and Womens Hospital ### 1360619###Co-Author######Brigham and Womens Hospital###
Co-Author: Sushama Kattinakere Sreedhara, MBBS, MSPH – Brigham and Womens Hospital
### @@@ Su Been Lee – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1658753###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Su Been Lee – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Theresa Oduol, BS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1659306###Co-Author###Research Assistant###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Theresa Oduol, BS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
###
The Comparative Effectiveness and Safety of Warfarin, Rivaroxaban, and Apixaban in Patients with Venous Thromboembolism: An Analysis of Three Real-World US Healthcare Databases

Geetha Iyer, MBBS, SM, PhD – Harvard School of Public Health ### 1062688###Presenting Author###Postdoctoral Fellow###Harvard School of Public Health###
Presenting Author: Geetha Iyer, MBBS, SM, PhD – Harvard School of Public Health
### @@@ Helen Tesfaye, PharmD, MSc – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1655578###Co-Author###Senior Research Specialist ###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Helen Tesfaye, PharmD, MSc – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Gregory Brill – Brigham and Women's Hospital ### 1655926###Co-Author###Programmer###Brigham and Women's Hospital###
Co-Author: Gregory Brill – Brigham and Women's Hospital
### @@@ Heidi Zakoul, BA – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1991320###Co-Author######Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###
Co-Author: Heidi Zakoul, BA – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### @@@ Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1046819###Co-Author###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###
Co-Author: Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### he/him/his @@@ Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School ### 1655839###Co-Author###Assistant Professor###Brigham and Women's Hospital and Harvard Medical School###
Co-Author: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
###
The Contribution of Immunization Information System Data to Claims-Based Capture of Vaccines Used to Prevent Mpox and Implications for Claims-Based Mpox Surveillance

Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1991129###Presenting Author###Epidemiologist###Optum Epidemiology###
Presenting Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Michael Wilkinson – Optum ### 1659347###Co-Author######Optum###
Co-Author: Michael Wilkinson – Optum
### @@@ Wafa Tarazi, PhD, MHPA – Optum Serve Consulting ### 1991285###Co-Author###Senior Consultant/ Epidemiologist###Optum Serve Consulting###
Co-Author: Wafa Tarazi, PhD, MHPA – Optum Serve Consulting
### @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US Food and Drug Administration ### 1655307###Co-Author###Epidemiologist/Health Statistician###US Food and Drug Administration###
Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Joann F. Gruber, PhD (she/her/hers) – US Food and Drug Administration ### 1991147###Co-Author###Epidemiologist###US Food and Drug Administration###
Co-Author: Joann F. Gruber, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Alexandra Stone, PhD – Optum Serve ### 1991303###Co-Author###Managing Consultant###Optum Serve###
Co-Author: Alexandra Stone, PhD – Optum Serve
### @@@ Grace Yang – OptumServe ### 1659346###Co-Author######OptumServe###
Co-Author: Grace Yang – OptumServe
### @@@ Kandace L. Amend, PhD – Optum Epidemiology ### 1063027###Co-Author###Senior Epidemiologist###Optum Epidemiology###
Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
### @@@ Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration ### 1655306###Co-Author###Health Statistician###US Food and Drug Administration###
Co-Author: Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration
### @@@ Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration ### 1358855###Co-Author###Associate Director Post-market Surveillance###US Food and Drug Administration###
Co-Author: Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration
### @@@ Richard A. Forshee, PhD – FDA/CBER ### 1358508###Co-Author###Deputy Director###FDA/CBER###
Co-Author: Richard A. Forshee, PhD – FDA/CBER
### @@@ Steven A. Anderson, PhD – FDA/CBER ### 1358532###Co-Author######FDA/CBER###
Co-Author: Steven A. Anderson, PhD – FDA/CBER
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology ### 1046832###Co-Author###Chief Scientific Officer###Optum Epidemiology###
Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
### @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1659086###Co-Author###Senior Epidemiologist###Optum Epidemiology###
Co-Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers
The Contribution of Immunization Information System Data to Claims-Based Vaccine Administration Capture Over Time and Implications for Claims-Based COVID-19 Vaccine Studies

Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1991129###Presenting Author###Epidemiologist###Optum Epidemiology###
Presenting Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Michael Wilkinson – Optum ### 1659347###Co-Author######Optum###
Co-Author: Michael Wilkinson – Optum
### @@@ Alexandra Stone, PhD – Optum Serve ### 1991303###Co-Author###Managing Consultant###Optum Serve###
Co-Author: Alexandra Stone, PhD – Optum Serve
### @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US Food and Drug Administration ### 1655307###Co-Author###Epidemiologist/Health Statistician###US Food and Drug Administration###
Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Wafa Tarazi, PhD, MHPA – Optum Serve Consulting ### 1991285###Co-Author###Senior Consultant/ Epidemiologist###Optum Serve Consulting###
Co-Author: Wafa Tarazi, PhD, MHPA – Optum Serve Consulting
### @@@ Grace Yang – OptumServe ### 1659346###Co-Author######OptumServe###
Co-Author: Grace Yang – OptumServe
### @@@ Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration ### 1655306###Co-Author###Health Statistician###US Food and Drug Administration###
Co-Author: Patricia C. Lloyd, ScM, PhD – US Food and Drug Administration
### @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Co-Author###Associate Director for Science###US Food and Drug Administration###
Co-Author: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration ### 1358855###Co-Author###Associate Director Post-market Surveillance###US Food and Drug Administration###
Co-Author: Azadeh Shoaibi, PhD, MHS – US Food and Drug Administration
### @@@ Richard A. Forshee, PhD – FDA/CBER ### 1358508###Co-Author###Deputy Director###FDA/CBER###
Co-Author: Richard A. Forshee, PhD – FDA/CBER
### @@@ Steven A. Anderson, PhD – FDA/CBER ### 1358532###Co-Author######FDA/CBER###
Co-Author: Steven A. Anderson, PhD – FDA/CBER
### @@@ Kandace L. Amend, PhD – Optum Epidemiology ### 1063027###Co-Author###Senior Epidemiologist###Optum Epidemiology###
Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology ### 1046832###Co-Author###Chief Scientific Officer###Optum Epidemiology###
Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
### @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1659086###Co-Author###Senior Epidemiologist###Optum Epidemiology###
Co-Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers
The COVID-19 Lobster Trap

Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Moderator###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###
Co-Moderator: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA ### 1358307###Co-Moderator###Associate Professor###Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA###
Co-Moderator: Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA
### she/her/hers
The EU Vaccine Monitoring Platform: a New Framework Leveraging European Union Pharmacoepidemiological Expertise and Data Sources to Monitor the Effectiveness and Safety of Vaccines

Luca Giraldi – European Medicines Agency ### 1991503###Co-Author######European Medicines Agency###
Co-Author: Luca Giraldi – European Medicines Agency
### @@@ Manuela Mura, DVM, PhD – European Medicines Agency ### 1991557###Co-Author###Scientific Officer###European Medicines Agency###
Co-Author: Manuela Mura, DVM, PhD – European Medicines Agency
### @@@ Lorna Leal, MD, PhD – European Medicines Agency ### 1991504###Co-Author###Scientific Specialist###European Medicines Agency###
Co-Author: Lorna Leal, MD, PhD – European Medicines Agency
### @@@ Kate Olsson – European Centre for Disease Prevention and Control ### 1991563###Co-Author######European Centre for Disease Prevention and Control###
Co-Author: Kate Olsson – European Centre for Disease Prevention and Control
### @@@ Karam Adel – European Centre for Disease Prevention and Control ### 1991564###Co-Author###Policy Expert, Vaccine-preventable Diseases###European Centre for Disease Prevention and Control###
Co-Author: Karam Adel – European Centre for Disease Prevention and Control
### @@@ Kim Brolin, PhD – European Centre for Disease Prevention and Control ### 1991562###Co-Author###Expert Vaccine Preventable Diseases###European Centre for Disease Prevention and Control###
Co-Author: Kim Brolin, PhD – European Centre for Disease Prevention and Control
### @@@ Piotr Kramarz – European Centre for Disease Prevention and Control ### 1991560###Co-Author######European Centre for Disease Prevention and Control###
Co-Author: Piotr Kramarz – European Centre for Disease Prevention and Control
### @@@ Sabrina Bacci – European Centre for Disease Prevention and Control ### 1991559###Co-Author######European Centre for Disease Prevention and Control###
Co-Author: Sabrina Bacci – European Centre for Disease Prevention and Control
### @@@ Marco Cavaleri – European Medicines Agency ### 1991555###Co-Author######European Medicines Agency###
Co-Author: Marco Cavaleri – European Medicines Agency
### @@@ Karl Ekdahl, MD, PhD, DTM&H – European Centre for Disease Prevention and Control ### 1991558###Co-Author###Head of Unit###European Centre for Disease Prevention and Control###
Co-Author: Karl Ekdahl, MD, PhD, DTM&H – European Centre for Disease Prevention and Control
### @@@ Peter Richard Arlett – European Medicines Agency ### 1074391###Co-Author###Head of Data Analytics and Methods Task Force###European Medicines Agency###
Co-Author: Peter Richard Arlett – European Medicines Agency
### @@@ Catherine Cohet, PhD (she/her/hers) – European Medicines Agency ### 1655442###Presenting Author###Pharmacoepidemiology/RWE Senior Specialist###European Medicines Agency###
Presenting Author: Catherine Cohet, PhD (she/her/hers) – European Medicines Agency
### she/her/hers
The Final Word
The impact of HLA-DQB1*06 alleles on COVID-19 vaccine effectiveness: an analysis of SARS-CoV-2 antibodies and breakthrough infections based on UK Biobank

Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358612###Presenting Author###DPhil Candidate & Research Assistant###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Presenting Author: Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Beatriz Mothe – HIV Unit-Infectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, CIBERINFEC, Spain ### 1991590###Co-Author######HIV Unit-Infectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, CIBERINFEC, Spain###
Co-Author: Beatriz Mothe – HIV Unit-Infectious Diseases Department, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, CIBERINFEC, Spain
### @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###
Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his
The Risk of Acute Transverse Myelitis after COVID-19 Vaccination: Self-Controlled Case Series Study

Eunsun Lim, MS – Department of Health Convergence, Ewha Womans University ### 1063363###Presenting Author###PhD Student###Department of Health Convergence, Ewha Womans University###
Presenting Author: Eunsun Lim, MS – Department of Health Convergence, Ewha Womans University
### @@@ Yoo Hwan Kim – Department of Neurology, Hallym University Sacred Heart Hospital ### 1991738###Co-Author######Department of Neurology, Hallym University Sacred Heart Hospital###
Co-Author: Yoo Hwan Kim – Department of Neurology, Hallym University Sacred Heart Hospital
### @@@ Na-Young Jeong, MS – Department of Health Convergence, Ewha Womans University ### 1062838###Co-Author###Ph.D. student###Department of Health Convergence, Ewha Womans University###
Co-Author: Na-Young Jeong, MS – Department of Health Convergence, Ewha Womans University
### @@@ Jong-Seok Bae – Department of Neurology, Kangdong Sacred Heart Hospital ### 1991739###Co-Author######Department of Neurology, Kangdong Sacred Heart Hospital###
Co-Author: Jong-Seok Bae – Department of Neurology, Kangdong Sacred Heart Hospital
### @@@ Nam-Kyong Choi – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea ### 1660178###Co-Author######Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea###
Co-Author: Nam-Kyong Choi – Department of Health Convergence, College of Science & Industry Convergence, Ewha Womans University, Seoul, Republic of Korea
###
The Risk of Serious Opioid-Related Harms Associated With Discharge Opioid and Non-Opioid Analgesic ‎Regimens Among Patients Hospitalized With Long-Bone Fracture

Kyle Hart – Department of Health Policy, VUMC ### 1993976###Co-Author######Department of Health Policy, VUMC###
Co-Author: Kyle Hart – Department of Health Policy, VUMC
### @@@ Ashley Leech – Department of Health Policy, VUMC ### 1993652###Co-Author######Department of Health Policy, VUMC###
Co-Author: Ashley Leech – Department of Health Policy, VUMC
### @@@ Avirath U. Vaidya – Department of Health Policy, VUMC ### 1993978###Co-Author######Department of Health Policy, VUMC###
Co-Author: Avirath U. Vaidya – Department of Health Policy, VUMC
### @@@ Stacie B. Dusetzina, PhD – Department of Health Policy, VUMC ### 1062587###Co-Author###Associate Professor###Department of Health Policy, VUMC###
Co-Author: Stacie B. Dusetzina, PhD – Department of Health Policy, VUMC
### @@@ Andrew Medvecz – 2Division of Acute Care Surgery, Department of Surgery, Vanderbilt University Medical Center ### 1993980###Co-Author######2Division of Acute Care Surgery, Department of Surgery, Vanderbilt University Medical Center###
Co-Author: Andrew Medvecz – 2Division of Acute Care Surgery, Department of Surgery, Vanderbilt University Medical Center
### @@@ Andrew D. Wiese, MPH, PhD – Department of Health Policy, VUMC ### 1062642###Presenting Author###Assistant Professor###Department of Health Policy, VUMC###
Presenting Author: Andrew D. Wiese, MPH, PhD – Department of Health Policy, VUMC
###
The use of ADHD medication and the risk of suicide attempt: A multinational population-based self-controlled case series study

Adrienne YL Chan, MPH – Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, ‐Epidemiology and ‐Economics, University of Groningen, Groningen, The Netherlands ### 1063197###Presenting Author###PhD Candidate###Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, ‐Epidemiology and ‐Economics, University of Groningen, Groningen, The Netherlands###
Presenting Author: Adrienne YL Chan, MPH – Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, ‐Epidemiology and ‐Economics, University of Groningen, Groningen, The Netherlands
### @@@ Amy Chan – University of Auckland ### 1991501###Co-Author######University of Auckland###
Co-Author: Amy Chan – University of Auckland
### @@@ Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1358157###Co-Author###Associate Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/his @@@ Sohee Park, PharmD, PhD – UCL School of Pharmacy ### 1302811###Co-Author######UCL School of Pharmacy###
Co-Author: Sohee Park, PharmD, PhD – UCL School of Pharmacy
### @@@ Chin-Yao Shen, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1063185###Co-Author###ph.D student###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Chin-Yao Shen, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom###
Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
### @@@ Kenneth KC Man, MPH, PhD, FRSPH (he/him/his) – UCL School of Pharmacy, University College London, London, United Kingdom ### 1358158###Co-Author###Lecturer in Pharmacoepidemiology and Medication Safety###UCL School of Pharmacy, University College London, London, United Kingdom###
Co-Author: Kenneth KC Man, MPH, PhD, FRSPH (he/him/his) – UCL School of Pharmacy, University College London, London, United Kingdom
### he/him/his @@@ Ian Chi Kei Wong, PhD (he/him/his) – The University of Hong Kong ### 1358232###Co-Author###Head of Department of Pharmacology and Pharmacy###The University of Hong Kong###
Co-Author: Ian Chi Kei Wong, PhD (he/him/his) – The University of Hong Kong
### he/him/his
The use of denosumab and the risk of incidence of diabetes in patients with osteoporosis

Albert Tzu-Ming Chuang, PharmD – Institute of Clinical Pharmacy and Pharmaceutical Sciences (CPPS), College of Medicine, National Cheng Kung University, Tainan, Taiwan. ### 1991536###Presenting Author###Research fellow###Institute of Clinical Pharmacy and Pharmaceutical Sciences (CPPS), College of Medicine, National Cheng Kung University, Tainan, Taiwan.###
Presenting Author: Albert Tzu-Ming Chuang, PharmD – Institute of Clinical Pharmacy and Pharmaceutical Sciences (CPPS), College of Medicine, National Cheng Kung University, Tainan, Taiwan.
### @@@ Huei-Kai Huang, MD – Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, and Department of Family Medicine and Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (H.K.H.) ### 1994118###Co-Author######Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, and Department of Family Medicine and Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (H.K.H.)###
Co-Author: Huei-Kai Huang, MD – Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, and Department of Family Medicine and Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (H.K.H.)
### @@@ Tzu-Chi Liao – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1360580###Co-Author######Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Tzu-Chi Liao – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Peter Pin-Sung Liu, MS – Center for Aging and Health, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan (P.P.S.L.) ### 1994119###Co-Author######Center for Aging and Health, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan (P.P.S.L.)###
Co-Author: Peter Pin-Sung Liu, MS – Center for Aging and Health, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan (P.P.S.L.)
### @@@ Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital, Keelung, Taiwan ### 1062628###Co-Author###Pharmacist###Keelung Chang Gung Memorial Hospital, Keelung, Taiwan###
Co-Author: Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital, Keelung, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1358157###Co-Author###Associate Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD, FISPE (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/his
Timing is Everything

Andrea V. Margulis, MD ScD FISPE – RTI Health Solutions ### 1046827###Co-Moderator###Senior Director###RTI Health Solutions###
Co-Moderator: Andrea V. Margulis, MD ScD FISPE – RTI Health Solutions
### @@@ Mollie E. Wood, PhD, MPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1659932###Co-Moderator###Assistant Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###
Co-Moderator: Mollie E. Wood, PhD, MPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
###
Town Hall: Global Regulatory Forum on Real-World Evidence; Sponsored by ISPE's RWE Collaborative SIG

Brian L. Strom, MD, MPH (he/him/his) – Rutgers, The State University of New Jersey ### 1302723###Moderator###Chancellor, Rutgers Biomedical and Health Sciences###Rutgers, The State University of New Jersey###
Moderator: Brian L. Strom, MD, MPH (he/him/his) – Rutgers, The State University of New Jersey
### he/him/his @@@ Robert Califf, MD (he/him/his) – U.S. Food and Drug Administration ### 2045658###Keynote Speaker###Commissioner of Food and Drugs###U.S. Food and Drug Administration###
Keynote Speaker: Robert Califf, MD (he/him/his) – U.S. Food and Drug Administration
### he/him/his @@@ Pamela Aung-Thin – Health Canada ### 2045662###Keynote Speaker###Assistant Deputy Minister###Health Canada###
Keynote Speaker: Pamela Aung-Thin – Health Canada
### @@@ Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration ### 1358504###Panelist###Associate Director of Pharmacoepidemiology###Oncology Center of Excellence, US Food and Drug Administration###
Panelist: Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration
### @@@ Melissa Kampman, PhD (she/her/hers) – Health Canada ### 1991542###Panelist###Manager, Data Analytics and Real-world Evidence Division###Health Canada###
Panelist: Melissa Kampman, PhD (she/her/hers) – Health Canada
### she/her/hers @@@ Yoshiaki Uyama, PhD – Pharmaceuticals and Medical Devices Agency ### 1360089###Panelist###Associate Executive Director###Pharmaceuticals and Medical Devices Agency###
Panelist: Yoshiaki Uyama, PhD – Pharmaceuticals and Medical Devices Agency
### @@@ Michal Hirsch-Vexberg, PharmD – Israel Ministry of Health ### 2045663###Panelist###Head of Pharmaceutical Registration Department###Israel Ministry of Health###
Panelist: Michal Hirsch-Vexberg, PharmD – Israel Ministry of Health
### @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656###Panelist###Head of Real World Evidence###European Medicines Agency###
Panelist: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
### @@@ Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency ### 1647043###Panelist###Head of Epidemiology###Medicines and Healthcare products Regulatory Agency###
Panelist: Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency
###
Tracking Trends Around The World

Jason Simeone, PhD (he/him/his) – Cytel ### 1660162###Co-Moderator###Senior Director, RWE###Cytel###
Co-Moderator: Jason Simeone, PhD (he/him/his) – Cytel
### he/him/his @@@ Gabriel Sanfelix-Gimeno, PharmD, PhD – FISABIO ### 1062657###Co-Moderator###Head, Health Services Research and Pharmacoepidemiology Unit###FISABIO###
Co-Moderator: Gabriel Sanfelix-Gimeno, PharmD, PhD – FISABIO
###
Trajectories of Antidepressant Adherence Before Tamoxifen Initiation Among US Women with Breast Cancer

Oluwadamilola Onasanya, MD, MPH, PhD Candidate – University of Maryland, Baltimore/Carelon Research ### 1659417###Presenting Author###PhD Candidate/Senior Researcher, Safety and Epidemiology###University of Maryland, Baltimore/Carelon Research###
Presenting Author: Oluwadamilola Onasanya, MD, MPH, PhD Candidate – University of Maryland, Baltimore/Carelon Research
### @@@ Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1359191###Co-Author###Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###
Co-Author: Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Udim Damachi, MSc – Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, USA ### 1659418###Co-Author###PhD Candidate###Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, USA###
Co-Author: Udim Damachi, MSc – Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, USA
### @@@ Eberechukwu Onukwugha, MS, PhD – University of Maryland School of Pharmacy, Baltimore, USA ### 1402427###Co-Author###Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy, Baltimore, USA###
Co-Author: Eberechukwu Onukwugha, MS, PhD – University of Maryland School of Pharmacy, Baltimore, USA
### @@@ Zafar Zafari, MSc, PhD – University of Maryland School of Pharmacy ### 1659618###Co-Author###Assistant Professor of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy###
Co-Author: Zafar Zafari, MSc, PhD – University of Maryland School of Pharmacy
### @@@ Paula Rosenblatt, MD – University of Maryland Medical Center, Baltimore MD, USA ### 1991719###Co-Author###Assistant Professor of Medicine###University of Maryland Medical Center, Baltimore MD, USA###
Co-Author: Paula Rosenblatt, MD – University of Maryland Medical Center, Baltimore MD, USA
### @@@ Wendy Camelo Castillo, MD, MSc, PhD (she/her/hers) – University of Maryland School of Pharmacy, Baltimore MD, USA ### 1062923###Co-Author###Assistant Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy, Baltimore MD, USA###
Co-Author: Wendy Camelo Castillo, MD, MSc, PhD (she/her/hers) – University of Maryland School of Pharmacy, Baltimore MD, USA
### she/her/hers
Tramadol use in the United States, 2004-2021

C. Andrew Basham, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital / Harvard Medical School, Boston MA ### 1991170###Presenting Author###Research Fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital / Harvard Medical School, Boston MA###
Presenting Author: C. Andrew Basham, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital / Harvard Medical School, Boston MA
### he/him/his @@@ Catherine S. Hwang, MD, MSPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1991430###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###
Co-Author: Catherine S. Hwang, MD, MSPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Heba H. Edrees, PharmD – Brigham and Women's Hospital ### 1359849###Co-Author######Brigham and Women's Hospital###
Co-Author: Heba H. Edrees, PharmD – Brigham and Women's Hospital
### @@@ Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School ### 1359931###Co-Author######Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
### @@@ Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School ### 1655839###Co-Author###Assistant Professor###Brigham and Women's Hospital and Harvard Medical School###
Co-Author: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
###
Translating Real-World Evidence and Other Pharmacoepidemiological Research Findings into Policy and Clinical Practice: How Well are We Doing and What are the Opportunities for Improvement?

Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc ### 1088147###Lead Speaker###Senior DIrector###Evidera, Inc###
Lead Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc
### @@@ Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania ### 1359970###Speaker###Associate Professor of Medicine and Epidemiology###Perelman School of Medicine at the University of Pennsylvania###
Speaker: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/his @@@ Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration ### 1358504###Speaker###Associate Director of Pharmacoepidemiology###Oncology Center of Excellence, US Food and Drug Administration###
Speaker: Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration
### @@@ Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University ### 1046831###Speaker###Professor and Director###Center for Pharmacoepidemiology and Treatment Science, Rutgers University###
Speaker: Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
### he/him/his
Treating Genital Herpes Infection During Pregnancy to Reduce the Risk of Preeclampsia: A Prospective Cohort Study of more than 89,000 Pregnant Women

De-Kun Li, MD, PhD (he/him/his) – Division of Research, Kaiser Foundation Research Institute ### 1655746###Presenting Author###Senior Research Scientist III###Division of Research, Kaiser Foundation Research Institute###
Presenting Author: De-Kun Li, MD, PhD (he/him/his) – Division of Research, Kaiser Foundation Research Institute
### he/him/his @@@ Jeannette Ferber, MPH – Division of Research, Kaiser Foundation Research Institute ### 1655845###Co-Author###Data Reporting and Analytics Biostatistics Consultant###Division of Research, Kaiser Foundation Research Institute###
Co-Author: Jeannette Ferber, MPH – Division of Research, Kaiser Foundation Research Institute
###
Treatment Effectiveness of Oral Disease-Modifying Agent in Multiple Sclerosis Adjusting for Adherence Trajectories

Jagadeswara Rao Earla, PharmD, MBA, PhD – Merck, Center for Observational and Real-World Evidence ### 1991699###Co-Author###Associate Director###Merck, Center for Observational and Real-World Evidence###
Co-Author: Jagadeswara Rao Earla, PharmD, MBA, PhD – Merck, Center for Observational and Real-World Evidence
### @@@ Jieni Li, MPH – University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy ### 1991698###Presenting Author###PhD Student/Research Assistant###University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy###
Presenting Author: Jieni Li, MPH – University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy
### @@@ George J. Hutton, MD – Baylor College of Medicine ### 1358575###Co-Author###Professor###Baylor College of Medicine###
Co-Author: George J. Hutton, MD – Baylor College of Medicine
### @@@ Rajender R. Aparasu, PhD – University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy ### 1358573###Co-Author###Professor###University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy###
Co-Author: Rajender R. Aparasu, PhD – University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy
###
Trends and inequalities in statin use for the primary and secondary prevention of cardiovascular disease

Rutendo Muzambi, MPharm, PhD (she/her/hers) – London School of Hygiene and Tropical Medicine ### 1991674###Presenting Author###Research Fellow###London School of Hygiene and Tropical Medicine###
Presenting Author: Rutendo Muzambi, MPharm, PhD (she/her/hers) – London School of Hygiene and Tropical Medicine
### she/her/hers @@@ Krishnan Bhaskaran – London School of Hygiene and Tropical Medicine ### 1360175###Co-Author######London School of Hygiene and Tropical Medicine###
Co-Author: Krishnan Bhaskaran – London School of Hygiene and Tropical Medicine
### @@@ Emily Herrett, PhD – London School of Hygiene and Tropical Medicine ### 1991300###Co-Author###Assistant Professor###London School of Hygiene and Tropical Medicine###
Co-Author: Emily Herrett, PhD – London School of Hygiene and Tropical Medicine
###
Trends in Initiation Patterns of Disease-Modifying Therapies for Multiple Sclerosis Among Commercially Insured Adults and Children in the United States, 2001-2020

Mackenzie Henderson, PharmD, MS – Daiichi Sankyo, Inc. ### 1657741###Co-Author######Daiichi Sankyo, Inc.###
Co-Author: Mackenzie Henderson, PharmD, MS – Daiichi Sankyo, Inc.
### @@@ Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA ### 1302719###Co-Author###Associate Professor of Pediatrics and Epidemiology###Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA###
Co-Author: Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA
### he/him/his @@@ Vikram Bhise, MD – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA ### 1991519###Co-Author######Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA###
Co-Author: Vikram Bhise, MD – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA
### @@@ Gian Pal, MD, MS – Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA ### 1991521###Co-Author######Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA###
Co-Author: Gian Pal, MD, MS – Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
### @@@ Greta A. Bushnell, PhD, MSPH – Center for Pharmacoepidemiology and Treatment Sciences ### 1358831###Co-Author###Assistant Professor###Center for Pharmacoepidemiology and Treatment Sciences ###
Co-Author: Greta A. Bushnell, PhD, MSPH – Center for Pharmacoepidemiology and Treatment Sciences
### @@@ Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ ### 1655382###Presenting Author###Assistant Professor of Pharmacy and Epidemiology###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ###
Presenting Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
###
Trends in prescribing preferences for anticoagulants among non-valvular atrial fibrillation patients in the UK with and without chronic kidney disease, 2010-2020

Julia Liaw, PharmD – Rutgers University ### 1655381###Presenting Author###MSc###Rutgers University###
Presenting Author: Julia Liaw, PharmD – Rutgers University
### @@@ Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ ### 1655382###Co-Author###Assistant Professor of Pharmacy and Epidemiology###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ###
Co-Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
### @@@ Deborah Liaw – University of South Florida ### 1991621###Co-Author######University of South Florida###
Co-Author: Deborah Liaw – University of South Florida
###
Trends in Psychotropic Polypharmacy Among Medicaid-Enrolled Youths in One US State, 2015-2020

Yueh-Yi Chiang, BS (she/her/hers) – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1991614###Presenting Author###PhD Candidate###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###
Presenting Author: Yueh-Yi Chiang, BS (she/her/hers) – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### she/her/hers @@@ Alejandro Amill-Rosario, PhD, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1655866###Co-Author###Research Associate###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###
Co-Author: Alejandro Amill-Rosario, PhD, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Haeyoung Lee – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1360378###Co-Author###Graduate student###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###
Co-Author: Haeyoung Lee – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Phuong TM Tran, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1658122###Co-Author###PhD student###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###
Co-Author: Phuong TM Tran, MPH – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
### @@@ Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA ### 1359191###Co-Author###Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy, Baltimore, Maryland, USA###
Co-Author: Susan dosReis, PhD – University of Maryland School of Pharmacy, Baltimore, Maryland, USA
###
Triple challenges – Small sample sizes in both exposure and control groups when scanning rare maternal outcomes in signal identification: A simulation study

Thuy N. Thai, PhD (she/her/hers) – Harvard Pilgrim Health Care Institute/Harvard Medical School ### 1062542###Presenting Author###Research Scientist###Harvard Pilgrim Health Care Institute/Harvard Medical School###
Presenting Author: Thuy N. Thai, PhD (she/her/hers) – Harvard Pilgrim Health Care Institute/Harvard Medical School
### she/her/hers @@@ Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###
Co-Author: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
### @@@ Elizabeth A. Suarez – Institute for Health, Health Care Policy and Aging Research, Rutgers University ### 1991274###Co-Author######Institute for Health, Health Care Policy and Aging Research, Rutgers University###
Co-Author: Elizabeth A. Suarez – Institute for Health, Health Care Policy and Aging Research, Rutgers University
### @@@ Jiwei He, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1991275###Co-Author######Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration###
Co-Author: Jiwei He, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Yueqin Zhao, PhD – Division of Biometrics 7, Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration ### 1359918###Co-Author######Division of Biometrics 7, Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration###
Co-Author: Yueqin Zhao, PhD – Division of Biometrics 7, Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration
### @@@ Di Zhang, PhD – Office of Biostatistics, Center for Drug Evaluation and Research ### 1360258###Co-Author######Office of Biostatistics, Center for Drug Evaluation and Research###
Co-Author: Di Zhang, PhD – Office of Biostatistics, Center for Drug Evaluation and Research
### @@@ Danijela Stojanovic, PharmD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ### 1359917###Co-Author######Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD###
Co-Author: Danijela Stojanovic, PharmD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
### @@@ Jane Liedtka, MD – 7. Division of Pediatric and Maternal Health, Center for Drug and Evaluation Research, US Food and Drug Administration ### 1360259###Co-Author###medical officer###7. Division of Pediatric and Maternal Health, Center for Drug and Evaluation Research, US Food and Drug Administration###
Co-Author: Jane Liedtka, MD – 7. Division of Pediatric and Maternal Health, Center for Drug and Evaluation Research, US Food and Drug Administration
### @@@ Abby F. Anderson, M.D. – Division of Urology, Obstetrics and Gynecology, Center for Drug and Evaluation Research, US Food and Drug Administration ### 1360260###Co-Author###Medical Officer###Division of Urology, Obstetrics and Gynecology, Center for Drug and Evaluation Research, US Food and Drug Administration###
Co-Author: Abby F. Anderson, M.D. – Division of Urology, Obstetrics and Gynecology, Center for Drug and Evaluation Research, US Food and Drug Administration
### @@@ José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1991185###Co-Author###Senior Pharmacist/Pharmacoepidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###
Co-Author: José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1358805###Co-Author###Director, Division of Pharmacovigilance I###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###
Co-Author: Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### she/her/hers @@@ Wei Liu – Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD ### 1358274###Co-Author######Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD###
Co-Author: Wei Liu – Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD
### @@@ Inna Dashevsky, Ms. – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1991276###Co-Author###Senior SAS Programmer###Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###
Co-Author: Inna Dashevsky, Ms. – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### @@@ Elizabeth Messenger-Jones – Harvard Pilgrim Health Care Institute ### 1991682###Co-Author######Harvard Pilgrim Health Care Institute###
Co-Author: Elizabeth Messenger-Jones – Harvard Pilgrim Health Care Institute
### @@@ Elizabeth Siranosian – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1991277###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###
Co-Author: Elizabeth Siranosian – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### @@@ Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1062626###Co-Author###Assistant Professor###Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###
Co-Author: Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### she/her/hers